Related Experiment Video
Updated: Jul 18, 2025

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Particular Aspects Related to CD4+ Level in a Group of HIV-Infected Patients and Associated Acute Coronary Syndrome
Mircea Bajdechi1,2, Adriana Gurghean1, Vlad Bataila3
1Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila" of Bucharest, 050474 Bucharest, Romania.
Insights
People with HIV infection face high cardiovascular risks. Lower CD4+ T-cell counts correlated with complex coronary lesions and increased risks, but not significantly different major adverse cardiac events at one year.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Individuals with HIV are prone to cardiovascular events due to chronic inflammation and atherosclerosis.
- Certain antiretroviral therapies can also elevate cardiovascular risk.
- Immune status, particularly CD4+ T-cell counts, is implicated in cardiovascular complications in HIV patients.
Purpose of the Study:
- To analyze the relationship between immune status (nadir CD4+ T-cell count) and cardiovascular outcomes in HIV patients with acute coronary syndrome.
- To assess the magnitude of coronary lesions, and thrombotic and bleeding risks in relation to immune status.
Main Methods:
- A longitudinal, retrospective study involving 50 HIV patients with acute coronary syndrome.
- Patients were divided into subgroups based on their nadir CD4+ T-cell count.
- Clinical, biological, and coronary lesion parameters were assessed, along with specific risk scores.
Main Results:
- Patients with poorer immune status (lower nadir CD4+ counts) exhibited more complex coronary lesions.
- Increased operative and bleeding risks were observed in patients with lower CD4+ counts at one year.
- No significant differences in major adverse cardiac and cerebrovascular events were found at 30 days and one year between subgroups.
Conclusions:
- While lower CD4+ T-cell counts in HIV patients are associated with more complex coronary artery disease and higher operative/bleeding risks, these factors did not translate to significantly worse major adverse cardiac and cerebrovascular event rates at one year.
- Immune status, as indicated by CD4+ nadir, is a relevant factor in assessing cardiovascular risk stratification in HIV-infected individuals.
Abstract:
People living with HIV infection are at high risk for cardiovascular events due to inflammation and atherosclerosis. Also, some antiretroviral therapies may contribute to the risk of cardiovascular complications. Immune status is highly dependent on the level of lymphocyte T helper CD4+. There are data suggesting that immune status and CD4+ cell count may be involved in the development of cardiovascular complications in these patients. Our study is longitudinal and retrospective and included a total number of 50 patients with HIV infection associated with acute coronary syndrome, divided into two subgroups based on the nadir of CD4+ cells. This study analyzes the relationship between the immune status of HIV patients, assessed by the nadir of the CD4+ T-cell count, and the outcome of these patients. Also, secondary endpoints were the assessment of the magnitude of coronary lesions and of thrombotic and bleeding risk assessed by specific scores. Clinical and biological parameters and also the extension and complexity of coronary lesions were assessed. Although patients with poor immune status had more complex coronary lesions and increased operative risk and bleeding risk at one year, this was not associated with significant differences in major adverse cardiac and cerebrovascular events at the 30-day and 1-year outcomes.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests

